A thyroid hormone antagonist that inhibits thyroid hormone action in vivo.

J Biol Chem

Section of Neurobiology, Physiology, and Behavior, University of California, Davis, California 95616-8519, USA.

Published: September 2002

We have characterized the newly developed thyroid hormone antagonist NH-3 in both cell culture and in vivo model systems. NH-3 binds Xenopus laevis thyroid hormone receptors directly in vitro and induces a conformation distinct from agonist-bound receptors. Transcriptional activation of a thyroid hormone response element-containing reporter gene is strongly inhibited by NH-3 in a dose-dependent manner. In addition, NH-3 prevents X. laevis thyroid hormone receptors from binding to the p160 family of co-activators GRIP-1 and SRC-1 in a two-hybrid assay. To assess the potency of the compound in vivo, we used induced and spontaneous X. laevis tadpole metamorphosis, a thyroid hormone-dependent developmental process. NH-3 inhibits thyroid hormone-induced morphological changes in a dose-dependent manner and inhibits the up-regulation of endogenous thyroid hormone-responsive genes. Spontaneous metamorphosis is efficiently and reversibly arrested by NH-3 with at least the same effectiveness as the thyroid hormone synthesis inhibitor methimazole. Therefore, NH-3 is the first thyroid hormone antagonist to demonstrate potent inhibition of thyroid hormone action in both cell culture- and whole animal-based assays.

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M205608200DOI Listing

Publication Analysis

Top Keywords

thyroid hormone
36
thyroid
12
hormone antagonist
12
inhibits thyroid
8
hormone
8
hormone action
8
laevis thyroid
8
hormone receptors
8
dose-dependent manner
8
nh-3
7

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!